chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fever; Joint pain; Pain near injection site; Pins and needle pains down her left arm to fingers; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Pins and needle pains down her left arm to fingers), CHILLS (Chills), PYREXIA (Fever), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain near injection site) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 037K20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, the patient experienced PARAESTHESIA (Pins and needle pains down her left arm to fingers) and VACCINATION SITE PAIN (Pain near injection site). On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever) and ARTHRALGIA (Joint pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Pins and needle pains down her left arm to fingers), CHILLS (Chills), PYREXIA (Fever), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain near injection site) outcome was unknown.      No concomitant medications were reported.  Patient took two Advil for the first night and then one Advil the next morning.   This case was linked to MOD-2021-372579, MOD-2021-372805 (Patient Link).
09/13/2021, @ 07:00 pm  I was sitting and started sweating profusely then was very dizzy and started to dry heave.  This lasted for 3 hours.  Severe Covid headache for 3 days after vaccine.
11/22/2021 Vaccination. Started to experience shoulder pain. I cannot remember which arm but it was notated by acupuncturist. 01/01/2022 Irregularities with menstrual cycle; I bled twice. I am always regular, every month, all my life.  05/01/2022 Missed menstrual cycle. Notified OBGYN and PCM. They want to keep an eye on me for the next month.
I felt very anxious for two days after the vaccine. Since I am prone to anxiety I could tell that it was above and beyond my regular anxiety. It felt like what I experienced when my buproprion dose was increased too much.
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 78 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular. Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 16-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
developed hives/pruritos on 11/15 worse on 11/16 and seen in clinic.  Improved on 11/17 and virtually resolved by 11/18/08
This spontaneous report was received from a 60 year old male consumer. On 09-JUN-2014 the patient was vaccinated with ZOSTAVAX, subcutaneous (dose not reported) when he should have received VARIVAX (Merck). No other concomitant therapies reported. No adverse symptoms reported. The outcome of the events was unknown. The causality of the events was unspecified. There was no PQC reported. Additional information has been requested.
Pt recvd 3 doses of Engerix-B & had nonresponse;
Constant aching pain in injection site that spreads down to fingers and up through shoulder. Aches like arthritis all the time.  Never lets up.
This spontaneous report was received from a nurse practitioner referred to a 53 year old female patient. No drug reactions/allergies. On 19-AUG-2014 the patient was vaccinated with a dose of ZOSTAVAX (Lot# unspecified), strength 19400 PFU, 0.65 ml, subcutaneous. Concomitant therapies included CELEXA, loratadine (manufacturer unknown), amoxicillin, SYNTHROID and FOSAMAX. The patient reported to the nurse practitioner that the injection site was red, sore and was swollen on unspecified dates in August 2014. The nurse practitioner stated that the swelling and redness was "almost resolved" without treatment. No treatment was given for all the events. The patient had sought medical attention-office visit. No lab diagnostics studies were performed. The patient's present status was recovering. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapy were not reported. On 10-JUN-2015, the patient received her first dose of GARDASIL 9 (lot# reported as K023432, expiry date 18-JUN-2016), her second dose of vaccine (lot# M003659, expiry date 20-SEP-2017) was administered later than recommended on 10-JUN-2016 and the third dose of GARDASIL 9 (lot# M011840, expiry date 01-FEB-2018) was administered earlier than recommended on 16-AUG-2016 (doses and routes of administrations were not reported). No adverse effects reported. Additional information has been requested.
No adverse events reported from patient at this time. The patient got a first dose of Moderna Covid vaccine on 3/18/21 from the clinic and received a 2nd dose of Pfizer Covid Vaccine from our clinic on 4/8/21..
On 2/27/01, 23:59 midnight (38 hours, post vax) client stated that she experienced soreness in the left chest area through to her back. States it hurts to turn head to the left. Pain relieved by aspirin. Referred to doctor.
Fever of 100 degrees, extreme chills even in high room temperatures and painstaking body aches. Itchy arm at vaccination site. Unable to sleep due to muscle aches.
Headache starting three hours after vaccines administration. Woke up with a headache the next day as well. Also developed itchy facial rash the following day on 8/7/2012 at 10:00 AM.
Headache, sore throat, sore arm at injection site - 9:30 pm; body aches, shivering, arm / fingers on injection arm cold 11:45 pm. Took Tylenol at 9:30 pm. Was only able to sleep a few hours. Took advil at 4:00 am, body aches, chills, coldness, and sore throat went away by 9:00 am, still dull headache and sore arm at injection site
Within a few hours, pt could not lift his arm. Friday 6/28/13, pt's arm was swollen, pt was weak and running a fever. Saturday AM - red streaks down arm, skin looked like it was going to "pop". Pt. went to ER, IV UNASYN and KEFLEX.
Appendicitis; culminated in appendectomy. Beginning 2 weeks from the initial vaccine, I began to experience sharp pains in the lower right side of my abdomen. The following day,  I went to the emergency room and was diagnosed with acute appendicitis and taken into emergency surgery.  Reviewing the CDC's website I became aware that appendicitis is listed as one of the three serious adverse event linked to the Pfizer COVID-19 vaccine.
Patient reported that around 6:30 of the day she received her flu shot, she experienced what she explained as convulsions. She also described them as thrashing movements. Then from about 7:00-10:00 she "didn't feel like herself." By 10:00 PM she felt completely fine and hasn't had any issues since.
I had some sort of reaction to the vaccine about 1-2 minutes after receiving it, and it was super scary and they had to call the paramedics.   After the pharmacist injected me, I felt the arm pain right away. No big deal. I walked over to the chair to sit for my 15 minutes. I was happy to be vaccinated and kind of saw it as my mini booster for my immune system that already beat COVID-19. As I sat there, the only thing I could say is, I felt a tingling cold sensation moving from my arm through me. Almost like I could feel the vaccine moving through my system. The tingling kept moving and I thought to myself, okay cool. I guess it's working. Awesome. But then my head felt cold, I felt tingling in my head, my mouth tasted like metal, saliva started to build in my mouth, I started to sweat, I felt overly sweaty all over my body, but my head felt cold and tingly.   I was staring straight ahead and everything started to go staticky, like a television set, and the static began to build and started to get starry. Everything in my vision started to fade. So I spoke out to say something weird was happening.  A man came over to talk to me and hold me up. He kept saying stuff but then my ears started ringing and I couldn't hear him anymore. I began to fade out as the stars got more intense. Then, as if it was just a mini reboot, my brain started to come back online and the picture in front of me began to fade back into view. I felt nauseous and still had a super metal taste in my mouth. They called the paramedics to give me a checkup. The metal taste in my mouth stayed the longest, but after about 45 minutes I felt well enough to go home.  On and off, I have this intense tingling inside my brain. It reminds me of a time when I was in the hospital on morphine. Just a tingling pins and needles sensation inside my head. Other than that, I am okay now. But I'm concerned it's some sort of reaction because I already had COVID-19.
Info has been received from a health professional concerning a 32 year old female who on 10/28/05 or 10/29/05 was vaccinated with a dose of MMRII. Shortly after vaccination the pt found out that she was pregnant. It was reported that the pt had a pregnancy test prior to vaccination that was negative. She did not feel well for several days after vaccination. It was reported that she was "less than 8 weeks gestation". Unspecified medical attention was sought. There was no product quality complaint involved. Additional info has been requested.
Abnormal (atypical)  trigeminal neuralgia; This spontaneous case was reported by a patient and describes the occurrence of TRIGEMINAL NEURALGIA (Abnormal (atypical)  trigeminal neuralgia) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A2AB, 033F21A, 24M20A and 027L20A) for COVID-19 prophylaxis.     Patient had no relevant past medical history and No allergies. Patient had never diagnosed with positive covid test or Covid 19.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2022, the patient experienced TRIGEMINAL NEURALGIA (Abnormal (atypical)  trigeminal neuralgia). The patient was treated with OXCARBAZEPINE (TRILEPTAL) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, TRIGEMINAL NEURALGIA (Abnormal (atypical)  trigeminal neuralgia) outcome was unknown.            It was reported that patient had received 2 primary series doses and 2 booster doses of Moderna vaccine all in recommended time frame.  The patient stated that he had an adverse impact (event) related to the 2nd booster dose and wanted to report that he had abnormal (atypical) trigeminal neuralgia.
2 TIA; Heart attack; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 08Mar2021 at 08:00 AM (Batch/Lot Number: EN6203) (at the age of 52-year-old) as dose 1, single, and via an unspecified route of administration, administered in the left arm on 2021 (Batch/Lot Number: ER8730) ((at the age of 52-year-old) as dose 2, single for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no COVID prior to vaccination. Medical history included high blood pressure (BP), high cholesterol, and allergy to bee stings. Concomitant medications included blood pressure medication and cholesterol medication. On an unspecified date in 2021, the patient experienced 2 TIA (transient ischemic attack) heart attack, which resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and hospitalization. The patient was hospitalized for 2 days. The patient was tested for COVID post vaccination which was a nasal swab with negative result in 2021. Therapeutic measures were taken as a result of the events which included stents, follow up appointments with multiple doctors. The outcome of the events was recovering.   Follow-up attempts are completed. No further information is expected.
Pfizer vaccination killed patient; This is a spontaneous report from a Pfizer-sponsored program, Corporate (Pfizer) Social Media Platforms. A contactable consumer reported for mother (patient) that a female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported that Pfizer vaccination killed reporter's mom (patient) on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Pfizer vaccination killed patient
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-MAY-2016, the patient was vaccinated with a dose of M-M-R II for prophylaxis (lot # L011528 , expiration date 16-JUN-2018; dose, dose number, route of administration were not reported). When a dose of PROQUAD may have been ordered by the physician. No adverse effects were reported. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Dec2020 at 14:45 as dose number unknown, single (Batch/Lot number: unknown) at the age of 27 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Astma" (unspecified if ongoing); "Known allergies: Medications and foods" (unspecified if ongoing); "Known allergies: Medications and foods" (unspecified if ongoing); "ptsd" (unspecified if ongoing); "bpd" (unspecified if ongoing); "POTS" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 and included treatment with Paxlovid.  Clinical course: Patient had no other medication in 2 weeks. Patient started Paxlovid treatment from 10Dec2022 to 12Dec2022 for COVID 19 Treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information and the temporal association, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of "DRUG INEFFECTIVE " and "COVID-19 ".
Pt received her 1st dose of Pfizer on 4/15/2021. Five minutes after receiving her vaccine, she passed out. Pt hit her left shoulder, which led to a bruise. The pt passed out an additional two times within five minutes of each other. Pt was alert and oriented afterwards. She has a history of syncope episodes post-injections. Vitals were stable and had transportation home. Pt was advised to seek emergency care in the event of any additional episodes. Pt will follow up at pharmacy in the morning.
Patient fainted and had convulsions for 5-10 seconds.  He came to and was just fine.
Swelling; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PRURITUS (Itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PRURITUS (Itching). At the time of the report, VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PRURITUS (Itching) outcome was unknown. Not Provided          No concomitant medications provided. No treatment drugs were reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up received on 27 Apr 2021
NERVE PAIN (SHOOTING PAIN IN BOTH LEGS, BOTH ARMS AND IN BETWEEN SHOULDERS AND UPPER BACK); CONSTANT TINGLING SENSATION; DISCOMFORT WHEN WALKING (ALMOST FELL DOWN ONCE); BRAIN FEELS DIZZY (LIGHTHEADEDNESS); MINOR ADVERSE EVENTS; This spontaneous report received from a patient concerned a 21 year old male. The patient's height, and weight were not reported. The patient's past medical history included back pain (nerve pain), and marijuana abuse, and concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient was previously treated with gabapentin for back pain. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: 07-AUG-2021) dose was not reported, administered on 29-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-JUN-2021, the subject experienced minor adverse events. On 07-JUL-2021, the subject experienced nerve pain (shooting pain in both legs, both arms and in between shoulders and upper back). On 07-JUL-2021, the subject experienced constant tingling sensation. On 07-JUL-2021, the subject experienced discomfort when walking (almost fell down once). On 07-JUL-2021, the subject experienced brain feels dizzy (lightheadedness). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from minor adverse events on 02-JUL-2021, and had not recovered from nerve pain (shooting pain in both legs, both arms and in between shoulders and upper back), constant tingling sensation, discomfort when walking (almost fell down once), and brain feels dizzy (lightheadedness). This report was non-serious.
Sore throat, severe headache, stiff neck, extreme lethargy, nausea
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 34-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Nov2022 as dose 4 (booster), single (Lot number: gj6665) at the age of 34 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Lot number: er8737), in left arm, on 27Apr2021 as dose 2, single (Lot number: er8735), in left arm and on 23Nov2021 as dose 3 (booster), single (Lot number: fg3527), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Lamictal, reaction(s): "Known allergies: Lamictal", notes: Known allergies: Lamictal. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: testing negative at that time; Positive, notes: positive test is a mild cough. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: It was unknown if the patient had receive other medication in 2weeks. The patient received Antiviral Product brand Paxlovid for COVID 19 Treatment started on 12Jan2023 and stopped on 16Jan20232. Rebound covid approximately 4 days following completion of paxlovid and testing negative at that time. At the time of writing this the only symptom along with positive test is a mild cough.
Narrative: 88 YEAR OLD FEMALE ADMITTED TO HOSPITAL ON 11/12/2021 WITH ACUTE COMPLICATED DIVERTICULITIS WITH MICROPERFORATIONS, AND C. DIFFICILE COLITIS. PATIENT TESTED POSITIVE FOR COVID-19 ON 11/22/2021. THIS DELAYED HER DISCHARGE FROM HOSPITAL TO HOSPICE NURSING HOME. SHE REMAINED ASYMPTOMATIC REGARDING COVID-19.
Heart palpitations, flu-like symptoms, chest tightness, difficulty drawing full breath, consistent with myocarditis
Child received all three vaccines. He then stood up and let his sister sit on his mom's lap while he watched. RN was turned toward the counter top and was writing a school note. RN then heard child fall and saw him laying on the ground. RN turned him on his side and he lost consciousness for about 5 seconds and body was very stiff. He was pale but quickly regained consciousness and was able to answer questions. Cool rag applied to neck and child given water. Child said he had ice cream bar for breakfast. He also said he had been very nervous getting the shot. He sat up a few minutes later and was able to walk out of office. RN advised mother to take him to ER since they do not have a primary care provider at this time.
Patient admitted to hospital on 12/04/2021  Patient s/p unwitnessed  fell at nursing home, out of her wheelchair, does not remember the event  Denies chest pain, shortness of breath, 02SAT 92% on RA Temp 100.8 F